Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mixed connective tissue disease.

R W Hoffman1, E L Greidinger

  • 1Division of Immunology and Rheumatology, University of Missouri and Department of Veterans Affairs Medical Center, Columbia 64212, USA. hoffmanR@health.missouri.edu

Current Opinion in Rheumatology
|September 16, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Autoimmune Basis for Raynaud's Phenomenon: Murine Model and Human Disease.

Arthritis & rheumatology (Hoboken, N.J.)·2018
Same author

Can SLE classification rules be effectively applied to diagnose unclear SLE cases?

Lupus·2016
Same author

Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.

Annals of the rheumatic diseases·2015
Same author

Diagnosis and risk stratification in patients with anti-RNP autoimmunity.

Lupus·2015
Same author

Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease.

Lupus·2013
Same author

Seed train development for the fermentation of bagasse from sweet sorghum and sugarcane using a simplified fermentation process.

Bioresource technology·2013

Mixed connective tissue disease (MCTD) involves U1-ribonucleoprotein (RNP) antibodies. Emerging research explores other autoantibodies, immune responses, and links to clinical outcomes like pulmonary hypertension in MCTD patients.

Area of Science:

  • Immunology
  • Rheumatology
  • Autoimmune Diseases

Background:

  • Mixed connective tissue disease (MCTD) is characterized by antibodies to the U1-ribonucleoprotein (RNP) complex.
  • Recent research has identified additional autoantibodies associated with MCTD.
  • Understanding the immune response in MCTD is crucial for diagnosis and treatment.

Purpose of the Study:

  • To review recent findings on autoantibodies in MCTD.
  • To discuss the immune responses against U1-RNP in human and animal models.
  • To explore the pathogenesis and clinical manifestations of MCTD, including pulmonary hypertension.

Main Methods:

  • Literature review of recent studies on MCTD.
  • Analysis of research on immune responses to U1-RNP.

Related Experiment Videos

  • Longitudinal patient data analysis focusing on clinical outcomes.

    • Main Results:

    • Beyond U1-RNP antibodies, other autoantibodies are recognized in MCTD.
    • Immune responses to U1-RNP have been further detailed in human and murine models.
    • Pulmonary hypertension significantly impacts disease outcomes in MCTD patients.

    Conclusions:

    • The immunological landscape of MCTD is broader than previously thought.
    • Further research into pathogenesis, including modified self-antigens or infectious agents, is warranted.
    • Clinical monitoring for complications like pulmonary hypertension is vital for managing MCTD.